In a study published in EMBO Reports, researchers led by Michael W. Lipscomb investigated how intracellular second messengers are regulated within antigen-presenting immune cells, identifying phosphodiesterase 1B, designated Pde1b, as an essential lineage-restricted regulator of cyclic nucleotide signaling in conventional type 1 dendritic cells and splenic macrophages. Cyclic adenosine monophosphate and cyclic guanosine monophosphate operate as potent suppressors of immune activation, yet the enzymatic machinery governing their baseline levels and stimulus-coupled breakdown across specific myeloid subsets has remained largely undefined. Using genetic knockout mouse models alongside pathogen challenges, single-cell transcriptomics, and multi-parameter flow cytometry, the investigative team demonstrated that selective ablation of Pde1b severely disrupts host immune defenses against bacterial infection. Mice deficient in this dual-specificity enzyme showed elevated cyclic nucleotide accumulation, attenuated bacterial clearance, impaired antigen-specific T cell expansion, and an aberrant skewing of myeloid transcriptional profiles toward alternative, immunosuppressive states.
The superfamily of phosphodiesterase enzymes comprises eleven gene families that exhibit varied tissue expression profiles, regulatory modalities, catalytic specificities, and enzymatic hydrolysis kinetics toward cyclic nucleotides. Within this family, calcium- and calmodulin-dependent phosphodiesterases modulate intracellular levels of cyclic adenosine monophosphate, abbreviated as cAMP, and cyclic guanosine monophosphate, or cGMP, through selective hydrolysis. This degradation directly controls the activation state of critical downstream effector kinases, particularly protein kinase A and protein kinase G. When intracellular cAMP and cGMP accumulate, these kinases activate regulatory cascades involving cyclic AMP response element-binding protein, glycogen synthase kinase 3, nuclear factor-kappa B, and protein phosphatase 2A, which collectively shape inflammatory responses. Prior literature established that elevated cyclic nucleotide concentrations exert potent anti-inflammatory effects that blunt antigen-presenting functions and alter T helper differentiation. Although Pde1b was known to increase during monocyte-to-macrophage differentiation, its systems-level in vivo role across distinct immune compartments remained undetermined.
To clarify the functional role of the enzyme in vivo, researchers examined global knockout mice featuring targeted disruption of exon 3 in Pde1b via a neomycin resistance cassette. Genotyping confirmed that homozygous knockout animals generated a genomic band approximately 150 base pairs smaller than wild-type littermates, producing unstable messenger RNA transcripts without detectable Pde1b protein on Western blots of splenic and brain tissues. Unbiased single-cell RNA sequencing of splenic cells from wild-type and knockout cohorts, profiling approximately 25,000 cells per genotype across four biological replicates, resolved fourteen distinct immune cell populations. Single-cell transcript quantification established that Pde1b expression in wild-type mice was restricted to dendritic cells and macrophages, with lower expression in neutrophils. Subsequent quantitative polymerase chain reaction and flow cytometric analyses of fluorescence-sorted populations verified robust Pde1b expression in conventional type 1 dendritic cells and macrophages, whereas conventional type 2 dendritic cells, B cells, and T cells showed no detectable expression.
Given this lineage-restricted expression profile, the researchers subjected mice to in vivo pathogen challenges to evaluate physiological antimicrobial defense. Following intravenous administration of a sublethal dose of live Listeria monocytogenes, splenic bacterial burdens were quantified at days four and six post-infection. Knockout animals maintained significantly elevated splenic colony-forming units compared to wild-type controls at both time points, demonstrating impaired bacterial clearance. To measure adaptive immune responses with antigen specificity, the investigators infected mice with an attenuated Listeria monocytogenes strain expressing the 2W model epitope. Utilizing 2W:I-Ab major histocompatibility complex class II tetramers, the authors tracked responder cells, finding a markedly reduced frequency of antigen-specific CD44-high CD4-positive T cells in knockout mice on days four and six post-infection relative to controls. Internal control populations of CD3-positive, CD4-negative T cells demonstrated no tetramer binding. Additionally, quantitative gene expression analysis of total spleen tissue at day six revealed elevated transcript levels of regulatory cytokines including interleukin-10, interleukin-17a, transforming growth factor-beta 1, and Ccr9.
Ex vivo and in vitro experiments next dissected whether the observed failure in antimicrobial defense stemmed from cell-intrinsic defects within dendritic cell or macrophage compartments. Primary bone marrow-derived macrophages isolated from knockout mice exhibited compromised intracellular clearance of Listeria over twenty-four hours in culture. This clearance failure was accompanied by significant transcriptional upregulation of arginase 1 and interleukin-10 alongside downregulated interleukin-12a expression, an alteration corroborated at the protein level by immunoassay measurements showing elevated secreted interleukin-10 and decreased interleukin-12p70. In parallel, bone marrow-derived dendritic cells cultured with Flt3 ligand from knockout animals displayed an impaired capacity to trigger proliferation of antigen-specific OT-I CD8-positive T cells upon exposure to ovalbumin-expressing Listeria. When primary dendritic cells were sorted into purified conventional subsets, only conventional type 1 dendritic cells lacking Pde1b exhibited this reduction in cross-priming capacity. Furthermore, co-culture supernatants from knockout conventional type 1 dendritic cells and OT-I responder cells contained substantially reduced concentrations of tumor necrosis factor-alpha, interferon-gamma, and interleukin-12p70.
To test whether the defect in antigen-specific cytotoxic T cell activation represented a dendritic cell-intrinsic mechanism in a living organism, the team executed in vivo adoptive cell transfer assays. Splenic conventional dendritic cells were isolated from wild-type or knockout donors and transferred intravenously into recipient knockout mice twenty-four hours prior to systemic infection with ovalbumin-expressing Listeria. Flow cytometric assessment revealed that transfer of wild-type dendritic cells partially restored expansion of antigen-specific CD8-positive T cells in knockout recipients. In contrast, adoptive transfer of knockout dendritic cells failed to rescue this proliferative defect, yielding responses indistinguishable from unmanipulated knockout animals. The authors confirmed successful engraftment by quantifying splenic CD11c-positive, major histocompatibility complex class II-positive cell frequencies. The partial nature of this rescue was consistent with the experimental architecture, wherein host animals retained endogenous Pde1b-deficient myeloid cells, including macrophages and granulocytes, while transferred wild-type cells coexisted alongside host dendritic cells, leaving open the possibility of cellular competition or incomplete reconstitution of the broader cooperating myeloid microenvironment.
To uncover how the absence of Pde1b alters dendritic cell functionality at baseline, the authors analyzed single-cell transcriptomic data from splenic conventional type 1 dendritic cells under steady-state conditions. While global subset development was intact, with flow cytometry confirming equivalent frequencies of conventional type 1 and type 2 dendritic cells between genotypes, knockout cells exhibited coordinated transcriptional alterations. Expression of multiple nuclear factor-kappa B-associated transcripts, such as Nfkbiz, Relb, Traf1, and Rel, was significantly decreased, pointing toward attenuated inflammatory preparedness. Concurrently, transcripts associated with interferon responsiveness and cytokine signaling, including Il15ra, Tyk2, Jak2, Il21r, Irf7, Nlrc5, and Isg15, were significantly downregulated in knockout conventional type 1 dendritic cells. Conversely, genes governing purinergic sensing and cyclic nucleotide regulation, such as P2ry14, Dgka, and Grk3, were upregulated. This distributed shift indicated that steady-state Pde1b activity is necessary to maintain conventional type 1 dendritic cells in a transcriptionally poised state optimal for type 1 immune induction, preventing drift into an immunoregulatory phenotype.
A complementary rewiring emerged upon closer examination of splenic macrophage populations. Transcriptional clustering resolved two distinct macrophage subclusters, with Pde1b expression strictly confined to subcluster 1 in wild-type mice. Although this Pde1b-positive subcluster remained identifiable in knockout animals, indicating that the enzyme is not required for lineage establishment, knockout macrophages displayed altered transcriptional signatures, including elevated expression of Cebpb, Folr2, Stat4, Arntl, Fgfr2, and Fn1. Upregulation of Cebpb and Fn1 aligns with activation states linked to tissue repair and immunosuppressive remodeling, while selective downregulation of formyl peptide receptor 2, denoted as Fpr2, suggested compromised danger sensing and resolution signaling. Flow cytometric immunophenotyping substantiated these molecular observations, demonstrating a measurable reduction in the overall frequency of F4/80-positive, CD11b-low macrophages in knockout mice. Furthermore, within the CD64-positive, CD11c-negative subset of these macrophages, cell surface expression of major histocompatibility complex class II molecules was markedly reduced, reflecting a diminished basal capacity for antigen presentation and immune surveillance.
The biochemical consequences of Pde1b deficiency were evaluated by directly quantifying second messenger dynamics and downstream kinase activity within purified myeloid subsets. Under steady-state conditions, sorted conventional type 1 dendritic cells and macrophages from knockout mice harbored significantly elevated concentrations of both intracellular cAMP and cGMP compared to wild-type counterparts. By contrast, conventional type 2 dendritic cells showed identical nucleotide levels across genotypes, confirming strict lineage specificity. Elevated cyclic nucleotide pools in knockout conventional type 1 dendritic cells and macrophages stimulated heightened catalytic activity of protein kinase A and protein kinase G, without compensatory changes in baseline transcript levels of cyclase or kinase subunits. Phospho-flow cytometric testing confirmed heightened phosphorylation of cyclic AMP response element-binding protein at serine 133, designated pCREB-S133, and glycogen synthase kinase 3 beta at serine 9, designated pGSK3beta-S9, in knockout cells. These post-translational modifications provide a direct mechanistic explanation for the repression of pro-inflammatory gene networks and induction of immunoregulatory programs.
Finally, the researchers addressed whether other phosphodiesterase enzymes could functionally compensate for Pde1b by profiling phosphodiesterase expression and conducting targeted pharmacological inhibition assays. Transcriptomic analysis revealed that conventional type 1 dendritic cells and macrophages express Pde4b and Pde7a alongside Pde1b, but neither gene demonstrated compensatory upregulation in knockout mice. In primary dendritic cell cultures stimulated with heat-killed Listeria, pharmacological inhibition using the Pde1b-preferential inhibitor DSR-141562 or the pan-PDE1 inhibitor ITI-214 markedly suppressed pro-inflammatory cytokine production, including tumor necrosis factor-alpha and interleukin-6, while elevating immunosuppressive interleukin-10. In contrast, the PDE4 inhibitor roflumilast produced only minor inhibitory effects, and the PDE7 inhibitor PDE7-IN-2 showed no measurable impact. Graded dose-response tests indicated that PDE1 inhibition produced substantially larger increases in intracellular cAMP than PDE4 inhibition under both resting and stimulated conditions. The authors concluded that calcium- and calmodulin-dependent Pde1b uniquely couples receptor-mediated calcium signaling to localized cyclic nucleotide hydrolysis, distinguishing it from basal regulators like PDE4 and establishing it as an indispensable controller of cell-mediated immunity in mice.
Subject of Research: Phosphodiesterase 1B regulation of cyclic nucleotide signaling and immune responses in myeloid cells
Article Title: Pde1b controls cyclic nucleotide signaling in cDC1 and macrophages to regulate immune responses
Article References: Rekowsky, L. L. O., da Silva, R. L. L., Seenarine, J. A., Resende, A. D. S., Macchietto, M., de Moura, T. R., Elizondo, D. M., & Lipscomb, M. W. (2026). Pde1b controls cyclic nucleotide signaling in cDC1 and macrophages to regulate immune responses. EMBO Reports, 27(20), 5904-5926. https://doi.org/10.1038/s44319-026-00924-z
Image Credits: AI Generated
DOI: 10.1038/s44319-026-00924-z
Keywords: Phosphodiesterase 1B, Pde1b, Cyclic Nucleotides, cAMP Signaling, cGMP Signaling, Conventional Type 1 Dendritic Cells, cDC1, Macrophages, Listeria monocytogenes, CD8 T Cell Priming, CD4 T Cell Activation, Protein Kinase A, Protein Kinase G, CREB Phosphorylation, GSK3beta Phosphorylation, Adoptive Transfer, Single-Cell RNA Sequencing, Myeloid Cell Regulation

